Deepika N. Shenoy

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A current challenge in prostate cancer treatment is how to differentiate aggressive disease from indolent prostate cancer. There is an urgent need to identify markers that would accurately distinguish indolent prostate cancer from aggressive disease. The aim of this study was to evaluate the role of PDZ Domain-binding kinase (PBK) in prostate cancer and to(More)
  • 1